InspireMD (NSPR) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
InspireMD insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $480K and 1 sold $289K of NSPR stock on the open market, including a cluster buy that began May 6, 2026.
Get emailed when insiders cluster-buy stocks like NSPR
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NSPR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $454K | 13 | $23K | 1 |
| Q1 2026 | — | 0 | $104K | 11 |
| Q4 2025 | $64K | 5 | — | 0 |
| Q3 2025 | — | 0 | — | 0 |
| Q2 2025 | — | 0 | $38K | 4 |
| Q1 2025 | — | 0 | $124K | 8 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 InspireMD, Inc. insiders reported open-market purchases totaling $480K, while 1 insider reported sales totaling $289K. The most recent cluster buy began on May 6, 2026, when 4 insiders bought a combined $422K. Among insiders with enough purchase history to measure, Paul Stuka (Director) has the highest Insider Score at 9. 0 of 24 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 29SEC | Paul StukaDirector | Buy | 20,000667,871 held (+3%) | $0.88 | $18K | -40.9% | 9 |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 10,0001,094,601 held (−1%) | $3.65 | $36K | -85.8% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 9,9231,116,806 held (−1%) | $2.55 | $25K | -79.6% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 22,7781,053,882 held (−2%) | $1.01 | $23K | -48.5% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 7,1861,079,601 held (−1%) | $2.51 | $18K | -79.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 7,0731,109,733 held (−1%) | $2.51 | $18K | -79.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 5,1321,104,601 held (−0%) | $2.46 | $13K | -78.9% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 3,8581,135,319 held (−0%) | $2.71 | $10K | -80.8% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 3,7601,086,787 held (−0%) | $2.51 | $9K | -79.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 3,6601,129,183 held (−0%) | $2.46 | $9K | -78.9% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,4761,132,843 held (−0%) | $2.61 | $6K | -80.1% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,4821,092,119 held (−0%) | $2.51 | $6K | -79.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,4541,126,729 held (−0%) | $2.51 | $6K | -79.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,9411,076,660 held (−0%) | $1.59 | $5K | -67.3% | — |
| May 21SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 1,5721,090,547 held (−0%) | $2.51 | $4K | -79.3% | — |
| May 15SEC | Paul StukaDirector | Buy | 10,000642,871 held (+2%) | $1.16 | $12K | -55.2% | 9 |
| May 15SEC | Paul StukaDirector | Buy | 5,000647,871 held (+1%) | $1.15 | $6K | -54.8% | 9 |
| May 13SEC | Paul StukaDirector | Buy | 65,626622,871 held (+12%) | $1.16 | $76K | -55.2% | 9 |
| May 13SEC | Marvin SlosmanCEO, President | Buy | 21,0003,556,658 held (+1%) | $1.20 | $25K | -56.7% | — |
| May 13SEC | Paul StukaDirector | Buy | 10,000632,871 held (+2%) | $1.19 | $12K | -56.3% | 9 |
| May 12SEC | Paul StukaDirector | Buy | 65,626622,871 held (+12%) | $1.16 | $76K | -55.2% | 9 |
| May 12SEC | Paul StukaDirector | Buy | 10,000632,871 held (+2%) | $1.19 | $12K | -56.3% | 9 |
| May 8SEC | Gary S RoubinDirector | Buy | 90,000834,478 held (+12%) | $1.18 | $106K | -55.9% | — |
| May 8SEC | Scott R. WardDirector | Buy | 73,255237,096 held (+45%) | $1.15 | $84K | -54.8% | — |
| May 8SEC | Scott R. WardDirector | Buy | 15,995163,841 held (+11%) | $1.15 | $18K | -54.8% | — |
| May 8SEC | Paul StukaDirector | Buy | 6,378531,599 held (+1%) | $1.15 | $7K | -54.8% | 9 |
| May 8SEC | Paul StukaDirector | Buy | 1,517525,221 held (+0%) | $1.12 | $2K | -53.6% | 9 |
| Feb 23SEC | Paul StukaDirector | Buy | 2,710391,628 held (+1%) | $1.81 | $5K | -71.3% | 9 |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 17,5931,174,664 held (−1%) | $1.62 | $29K | -67.9% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 12,3951,149,077 held (−1%) | $1.65 | $20K | -68.5% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 8,4111,166,253 held (−1%) | $1.57 | $13K | -66.9% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 5,0001,144,077 held (−0%) | $1.65 | $8K | -68.5% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 4,7811,161,472 held (−0%) | $1.66 | $8K | -68.7% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,9001,141,177 held (−0%) | $1.63 | $5K | -68.1% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,9551,192,257 held (−0%) | $1.59 | $5K | -67.3% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,9091,197,462 held (−0%) | $1.58 | $5K | -67.1% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,2501,195,212 held (−0%) | $1.61 | $4K | -67.7% | — |
| Feb 2SEC | Shane Thomas GleasonChief Commercial Officer | Sell | 2,0001,139,177 held (−0%) | $1.60 | $3K | -67.5% | — |
| Dec 11SEC | Paul StukaDirector | Buy | 5,073391,628 held (+1%) | $1.81 | $9K | -71.3% | 9 |
| Dec 8SEC | Paul StukaDirector | Buy | 5,073388,918 held (+1%) | $1.86 | $9K | -72.0% | 9 |
| Dec 5SEC | Paul StukaDirector | Buy | 10,130383,845 held (+3%) | $1.85 | $19K | -71.9% | 9 |
| Nov 13SEC | Paul StukaDirector | Buy | 13,431373,715 held (+4%) | $1.62 | $22K | -67.9% | 9 |
Insiders at InspireMD, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Paul StukaDirector | $284K | — | May 29, 2026 | 9 |
| Gary S RoubinDirector | $106K | — | May 8, 2026 | — |
| Scott R. WardDirector | $103K | — | May 8, 2026 | — |
| Shane Thomas GleasonChief Commercial Officer | — | $289K | May 21, 2026 | — |
| Marvin SlosmanCEO, President | $25K | — | May 13, 2026 | — |
NSPR stock: common questions
Are InspireMD, Inc. insiders buying NSPR stock?
In the past 12 months, 4 insiders reported open-market purchases of NSPR worth $480K. The latest was Director Paul Stuka bought $18K of NSPR at $0.88.
Are InspireMD, Inc. insiders selling NSPR stock?
1 insiders reported sales worth $289K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NSPR's 52-week range?
Over the past year NSPR has traded between $0.48 and $2.42. It last closed at $0.52 on Oct 9, 2026.